Healthcare -
Biotechnology - NASDAQ - US
$ 8.33
18 %
$ 1.34 B
Market Cap
-3.82
P/E
NVAX - DEPRECIATION & AMORTIZATION
Depreciation & Amortization NVAX - Novavax, Inc.
41.2 M
LAST VALUE
80.45%
2 YEAR CAGR
38.26%
5 YEAR CAGR
31.88%
10 YEAR CAGR